Q3 2024 Regeneron Reports Third Quarter 2024 Financial and Operating Results Regeneron Pharmaceuticals Q3 2024 Earnings Conference Call REGN October 2024 Corporate Presentation 2.1 MB Regeneron Pharmaceuticals Q3 2024 Earnings Conference Call Transcript 643 KB Form 10-Q Annual Reports Date Title 2023 Annual Report 2023 Annual Report Proxy Statements Date Title 2024 Proxy Statement 2024 Proxy Statement Form 10-K Filing date View Feb 05, 2024 View HTML 0001804220-24-000009.pdf 0001804220-24-000009.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Feb 06, 2023 View HTML 0001804220-23-000008.pdf 0001804220-23-000008.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Form 10-Q Filing date View Oct 31, 2024 View HTML 0001804220-24-000040.pdf 0001804220-24-000040.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Aug 01, 2024 View HTML 0001804220-24-000028.pdf 0001804220-24-000028.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Interactive Analyst Center Interactive and downloadable financial data for investors and analysts View Analyst Center